Abbott Laboratories
ABT
Hisse Senetlerindeki Sıralama
#103
Abbott Laboratories, along with its affiliated entities, is a global healthcare... Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Hisse Fiyatı
$104.70
Son senkronizasyon: 2026-10-16
Piyasa Değeri
$181.16B
Değişim (1 gün)
-0.09%
Değişim (1 yıl)
-18.26%
Ülke
US
Ticaret Abbott Laboratories (ABT)
Kategori
Healthcare
Abbott Laboratories (ABT) için temettü geçmişi
Abbott Laboratories (hisse sembolü: ABT) toplam 73 temettü ödemesi yaptı.
Tüm temettülerin toplamı (hisse bölünmeleriyle ayarlanmış): $27.44
Temettü verimi (TTM): 0.0213
Tüm temettülerin toplamı (hisse bölünmeleriyle ayarlanmış): $27.44
Temettü verimi (TTM): 0.0213
Abbott Laboratories (ABT) için 2008 ile 2026 arasındaki temettü ödemeleri
Yıllık temettü ödemeleri
| Yıl | Temettü (hisse bölünmesiyle ayarlanmış) | Değiştir |
|---|---|---|
| 2026 (TTM) | $0.5428 | -73.70% |
| 2025 | $2.06 | -6.18% |
| 2024 | $2.20 | 7.84% |
| 2023 | $2.04 | 8.56% |
| 2022 | $1.88 | 4.40% |
| 2021 | $1.80 | 25.00% |
| 2020 | $1.44 | 12.50% |
| 2019 | $1.28 | 14.29% |
| 2018 | $1.12 | 5.66% |
| 2017 | $1.06 | 1.92% |
| 2016 | $1.04 | 8.33% |
| 2015 | $0.96 | 9.09% |
| 2014 | $0.88 | 57.14% |
| 2013 | $0.56 | -72.14% |
| 2012 | $2.01 | 6.91% |
| 2011 | $1.88 | 9.30% |
| 2010 | $1.72 | 10.26% |
| 2009 | $1.56 | 11.03% |
| 2008 | $1.41 | 0.00% |
Tüm temettü ödemelerinin listesi
| Yıl | Temettü | Değiştir |
|---|---|---|
| 2026 (TTM) | $0.5428 | -73.70% |
| 2025 | $2.06 | -6.18% |
| 2024 | $2.20 | 7.84% |
| 2023 | $2.04 | 8.51% |
| 2022 | $1.88 | 4.44% |
| 2021 | $1.80 | 25.00% |
| 2020 | $1.44 | 12.50% |
| 2019 | $1.28 | 14.29% |
| 2018 | $1.12 | 5.66% |
| 2017 | $1.06 | 1.92% |
| 2016 | $1.04 | 8.33% |
| 2015 | $0.96 | 9.09% |
| 2014 | $0.88 | 57.14% |
| 2013 | $0.56 | -72.14% |
| 2012 | $2.01 | 6.91% |
| 2011 | $1.88 | 9.30% |
| 2010 | $1.72 | 10.26% |
| 2009 | $1.56 | 11.03% |
| 2008 | $1.41 | 0.00% |
Benzer şirketler veya rakipler için temettü ödemeleri
| Şirket | Temettü ödemesi sayısı | Ülke |
|---|---|---|
| 178.00% |
IE
|
|
| 85.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
DE
|
|
| 0.00% |
US
|
